Overall, it was a decent week for London’s junior markets, with AIM100 up 0.39% to 4,034 though it lagged against the Footsie, which rose more than 0.8%.
4d Pharma PLC (AIM:DDDD) Blautix Phase II Clinical Trial Results Published
4D pharma’s Blautix® Phase II Clinical Trial Results Published in Alimentary Pharmacology & Therapeutics
Share Talk Weekly Stock Market News, Sunday 9th October 2022
During the week Zak was fortunate enough to bump into a stockbroker who, with more than 30 years in the saddle, can be regarded as one of the leaders in
4d Pharma PLC (AIM:DDDD) MRx0518 poster presentations at SITC 2022
4D pharma Announces Two Presentations at The Society for Immunotherapy of Cancer Annual Meeting (SITC 2022)
Share Talk Weekly Stock Market News, Sunday 2nd October 2022
Looking at the daily chart of the FTSE Small Cap index the good news is that we appear to have hit the floor of the falling trend channel from the
4d Pharma PLC (AIM:DDDD) Update on Suspension of Trading on AIM – Delay to publication of Interim Results
Leeds, UK, September 28, 2022 , – 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from
Share Talk Weekly Stock Market News, Monday 29th August 2022
Ofgem increased the energy price cap Friday to £3,549 per household. One pressure group stated it will sue Ofgem for its 80% price-cap increase, which it claims will ‘devastate families’ in
4d Pharma PLC (AIM:DDDD) Publication of preclinical autism research
4D pharma Announces Publication of Preclinical Research Showing Live Biotherapeutic MRx0006 Efficacy in Animal Model of Autism Spectrum Disorder
Share Talk Weekly Stock Market News, Sunday 26th June 2022
Another eventful week, the markets are still not pricing in positive news updates and investors are feeling the pressure. Do you top-up and take advantage, bottom draw and sit on
Share Talk Weekly Small Cap Movers & Shakers, Saturday 25th June 2022
Clontarf Energy Plc (AIM: CLON) share price sprung to life when Share talk announced they would be speaking with David Horgan, Chairman of the company.
4d Pharma PLC (AIM:DDDD) Temporary Suspension
Leeds, UK, 24 June 2022 , – 4D pharma plc (AIM: DDDD, Nasdaq LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug
